| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/01/2004 | US20040002068 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 01/01/2004 | US20040002066 36 human secreted proteins |
| 01/01/2004 | US20040002059 Screening method and a screening system capable of selecting agents capable of interfering with this protein-protein interaction; selection of agents capable of modulating this protein-protein interaction for treatment and control of PV |
| 01/01/2004 | US20040002058 Chimeric capsid proteins and uses thereof |
| 01/01/2004 | US20040002054 Associated with connective tissue diseases, progeroid disorders, and aging; methods for isolating such molecules; and the use of such molecules in human and veterinary practice |
| 01/01/2004 | US20040001897 Skin vitalizing composition for external use anti-aging preparation |
| 01/01/2004 | US20040001893 Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
| 01/01/2004 | US20040001875 Antidiabetic agents; controlling concentration of protein, carbohydrates, fats |
| 01/01/2004 | US20040001872 Using polyoxyethylene glycol solutions; mixing with drug |
| 01/01/2004 | US20040001867 Vectors for molecule delivery to CD11b expressing cells |
| 01/01/2004 | US20040001865 Methods for treating priapism |
| 01/01/2004 | US20040001855 Monocyte locomotion inhibitory factor |
| 01/01/2004 | US20040001852 Deactivation antigen protein; anticancer agents; Aids therapy |
| 01/01/2004 | US20040001850 Dna sequences; genetic engineering |
| 01/01/2004 | US20040001848 Alzheimer's disease; vaccines; induction immunology response |
| 01/01/2004 | US20040001842 Inducing antibodies in situ; binding; antitumor agents, anticancer agents |
| 01/01/2004 | US20040001840 Cancer-linked gene as target for chemotherapy |
| 01/01/2004 | US20040001839 Anticancer agents; antiinflammatory agents; autoimmune diseases |
| 01/01/2004 | US20040001836 Mixture of polypeptide with carrier |
| 01/01/2004 | US20040001835 Prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents |
| 01/01/2004 | US20040001831 Methods and compositions for the diagnosis and treatment of demyelinating inflammatory disorders |
| 01/01/2004 | US20040001829 Methods for selectively stimulating proliferation of T cells |
| 01/01/2004 | US20040001826 Genetic engineering; binding collagen to glycoprotein; hemostatic response to injury |
| 01/01/2004 | US20040001824 Cell proliferation inhibitors |
| 01/01/2004 | US20040001822 Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 01/01/2004 | US20040001821 Topical applying kinase to eye surface |
| 01/01/2004 | US20040001820 Polynucleotides; antiinflammatory agents; modulate immunologyresponse |
| 01/01/2004 | US20040001819 Recombinant kid pregastric esterase and methods for its production and use |
| 01/01/2004 | US20040001818 Prevention endothelial cell migration; antiproliferative agent; diaphorase inhibitor |
| 01/01/2004 | US20040001817 Mixture of vitamions, minerals, digestive enzyme, hormone and amino acids |
| 01/01/2004 | US20040001816 Enriched platelet wound healant |
| 01/01/2004 | US20040001808 Compositions and methods for the use of Bcl-2 transfected neurons |
| 01/01/2004 | US20040001807 Genetic engineering bone marrow cells; therapy for cardiovascular disorders |
| 01/01/2004 | US20040001806 Culture product containing interleukins and colony stimulanting factor; antitumor agents |
| 01/01/2004 | US20040001804 LLT uses thereof in immune system modulation |
| 01/01/2004 | US20040001803 Effectors of innate immunity determination |
| 01/01/2004 | US20040001802 Immobilized tumor necrosis factor |
| 01/01/2004 | US20040001801 Conjugates activated by cell surface proteases and therapeutic uses thereof |
| 01/01/2004 | US20040001790 Methods for diagnosis and treatment of tumours |
| 12/31/2003 | WO2004001424A1 Materials and methods for inductions of immune tolerance |
| 12/31/2003 | WO2004001410A1 Methods for identifying glucose uptake modulators |
| 12/31/2003 | WO2004001384A2 Methods for inhibiting angiogenesis, cell migration, cell adhesion, and cell survival |
| 12/31/2003 | WO2004001381A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 12/31/2003 | WO2004001072A2 Method for diagnosis of colorectal tumors |
| 12/31/2003 | WO2004001068A2 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 12/31/2003 | WO2004001061A2 Antisense modulation of heme oxygenase 1 expression |
| 12/31/2003 | WO2004001048A1 Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 12/31/2003 | WO2004001047A1 Novel promoter |
| 12/31/2003 | WO2004001045A1 Inhibition of nuclear receptors |
| 12/31/2003 | WO2004001038A1 Novel gene and protein participating in neuralization of cells or tissues and utilization thereof |
| 12/31/2003 | WO2004001027A1 Oligonucleotide inhibitors of mbd2/dna demethylase and uses thereof |
| 12/31/2003 | WO2004001023A2 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 12/31/2003 | WO2004001020A2 Methods and means to promote gut absorption |
| 12/31/2003 | WO2004001014A2 Osteopontin, oligodendrocytes and myelination |
| 12/31/2003 | WO2004001013A2 Inhibition of gene expression in vertebrates using double-stranded rna (rnai) |
| 12/31/2003 | WO2004001009A2 Apo-2 ligand/trail variants and uses thereof |
| 12/31/2003 | WO2004001008A2 Kinases and phosphatases |
| 12/31/2003 | WO2004001005A2 Intracellular signaling proteins |
| 12/31/2003 | WO2004001004A2 Membrane associated tumor endothelium markers |
| 12/31/2003 | WO2004000997A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 12/31/2003 | WO2004000996A2 Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation |
| 12/31/2003 | WO2004000993A2 Oxytocin as cardiomyogenesis inducer and uses thereof |
| 12/31/2003 | WO2004000887A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 12/31/2003 | WO2004000883A1 Regulation of human growth hormone-releasing hormone receptor |
| 12/31/2003 | WO2004000881A1 Dna sequence and recombinant production of the grass pollen allergen phl p4 |
| 12/31/2003 | WO2004000875A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 12/31/2003 | WO2004000870A2 Two synthetic peptides for treatment and prevention of cancers |
| 12/31/2003 | WO2004000858A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 12/31/2003 | WO2004000838A1 Peptidic compounds as cysteine protease inhibitors |
| 12/31/2003 | WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 12/31/2003 | WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 12/31/2003 | WO2004000802A2 Scaffolded maleimide clusters for multivalent peptide assembly |
| 12/31/2003 | WO2004000415A2 Tissue reconstruction and regeneration |
| 12/31/2003 | WO2004000368A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 12/31/2003 | WO2004000367A1 Ace2 activation for treatment of heart, lung and kidney disease and hypertension |
| 12/31/2003 | WO2004000366A1 Pegylated factor vii glycoforms |
| 12/31/2003 | WO2004000363A1 Process for producing sustained-release composition |
| 12/31/2003 | WO2004000360A1 Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis |
| 12/31/2003 | WO2004000359A1 Topical pharmaceutical composition comprising skin penetration enhancers for the treatment of warts |
| 12/31/2003 | WO2004000354A2 Method of treating the syndrome of lipodystrophy |
| 12/31/2003 | WO2004000353A1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
| 12/31/2003 | WO2004000349A1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 12/31/2003 | WO2004000348A1 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 12/31/2003 | WO2004000347A1 Stabilised solid compositions of factor vii polypeptides |
| 12/31/2003 | WO2004000344A1 Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 12/31/2003 | WO2004000328A1 Biosynthesis of hif |
| 12/31/2003 | WO2004000297A1 Nutritional or pharmaceutical compositions for increasing the creatine response of organisms |
| 12/31/2003 | WO2004000289A2 Preparations for the intranasal application of selected cgrp antagonists derived from amino acids and a method for their production |
| 12/31/2003 | WO2004000286A1 Microcapsules for the delayed, controlled release of perindopril |
| 12/31/2003 | WO2004000266A1 Method for oral transmucosal delivery of interferon |
| 12/31/2003 | WO2004000237A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 12/31/2003 | WO2004000231A2 Methods and compositions for the treament of cancer |
| 12/31/2003 | WO2004000228A2 Methods for preventing and treating microbial infections by modulating transcription factors |
| 12/31/2003 | WO2004000222A2 The use of bacterial phage associated lysing proteins for treating bacterial dental caries |
| 12/31/2003 | WO2004000211A2 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing |
| 12/31/2003 | WO2004000208A2 System and method for inhibiting cellular proliferation with tachykinins |
| 12/31/2003 | WO2004000207A2 Toxin-phage bacteriocide antibiotic and uses thereof |
| 12/31/2003 | WO2004000204A2 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 12/31/2003 | WO2004000102A2 Method for predicting response to epidermal growth factor receptor-directed therapy |
| 12/31/2003 | WO2004000042A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |